1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed., American Psychiatric Association, Washington, 1980
2. Bourin M, Ortega A, Larousse C. Viloxazine as a beta-mimetic antidepressant drug. Neuropsychobiology 17: 35–40, 1987
3. Brion S, Chevalier JF. Tolérance à long terme de la viloxazine. Encéphale 8: 511–521, 1982
4. Covi L, Lipman SR. Primary depression or primary anxiety. A possible psychometric approach to a diagnostic dilemma. Clinical Neuropharmacology 7 (Suppl. 1): 924–925, 1984
5. Davies B, Joshua S, Burrows G, Poynton C. A sequential trial of viloxazine (Vivalan) and imipramine in moderately depressed patients. Medical Journal of Australia 1: 521–522, 1977